NCT07407283 2026-02-12A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/2 Not yet recruiting100 enrolled
NCT03874455 2024-03-22Tazemetostat Expanded Access Program for Adults With Solid TumorsIpsenNo longer available